chevron_leftBack
As of 24 April 2025, Senseonics Holdings, Inc. has a market cap of $480.48M USD, ranking #12146 globally and #2313 in the United States. It ranks #1187 in the Healthcare sector, and #132 in the Medical Devices industry.
Key Stats
Market Cap
$480.48MUSD
Enterprise Value
$466.94MUSD
Revenue (TTM)
$22.47MUSD
EBITDA (TTM)
-$73.37MUSD
Net Income (TTM)
-$78.62MUSD
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Medical Devices
CEO
Timothy Goodnow
open_in_new
Employees
117
Founded
1996
Website
senseonics.com
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| 6.4% | 23% | -1.6% | -26% | 101% | 83% |
Upcoming Earnings
Earnings Date
Mon, May 12
Earnings Time
bedtime
After Close
EPS Estimate
-$0.0200
Revenue Estimate
$5.57M
10% yoy
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
SENS
Senseonics Holdings Inc
ISIN: US81727U1051
Shares Out.:
Shares Outstanding:
654.216M1
Shares Float:
604.252M2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
NQ:
NASDAQ:
BA:
Barron's:
MS:
Morningstar:
|
0.7371 USD |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About Senseonics Holdings, Inc.
Senseonics Holdings, Inc., a commercial-stage medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally. The company’s products include Eversense, Eversense XL, Eversense E3, and Eversense 365, which are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and an app for real-time diabetes monitoring and management. It serves healthcare providers and patients through a network of distributors and strategic fulfillment partners. The company was founded in 1996 and is headquartered in Germantown, Maryland.
